J. Kish

发表

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.

J. Ensley, D. Schuller, H. Wagner, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

J. Jacobs, T. Pajak, J. Cooper, 2004, The New England journal of medicine.

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).

B. Costello, J. Riess, B. Goh, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of conventional morphologic analysis on response rates and survival in patients with advanced head and neck cancers treated initially with cisplatin‐containing combination chemotherapy

J. Jacobs, J. Ensley, J. Crissman, 1986, Cancer.

A phase II trial of interferon‐α and 5‐fluorouracil in patients with advanced renal cell carcinoma: A Southwest Oncology Group study

E. Crawford, B. Blumenstein, R. Flanigan, 1996 .

Assessing the impact of user-centered research on a clinical trial eHealth Tool via a randomized control study

B. Hesse, H. Massett, M. Wang, 2011 .

Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real‐world claims data analysis

J. Kish, S. Chaudhari, D. Sussman, 2017, International journal of clinical practice.

The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment.

K. Brintzenhofeszoc, B. Murphy, Z. Zumsteg, 2017, International journal of radiation oncology, biology, physics.

Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study.

C. Coltman, J. Ensley, J. Rinehart, 1987, Cancer treatment reports.

Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study

Joaquim M Farinhas, C. Chung, M. Schell, 2021, Cancers.

Metastatic squamous cell carcinoma of an unknown primary localized to the neck. Advantages of an aggressive treatment

F. D. De Braud, W. Sakr, J. Ensley, 1989, Cancer.

Improved complete response rate and survival in advanced head and neck cancer after three‐course induction therapy with 120‐hour 5‐FU infusion and cisplatin

J. Jacobs, J. Crissman, J. Kinzie, 1985, Cancer.

Determining optimal follow‐up in the management of human papillomavirus‐positive oropharyngeal cancer

T. Strom, T. Padhya, L. Harrison, 2016, Cancer.

Comparison of every 3 week cisplatin or weekly cetuximab with concurrent radiotherapy for locally advanced head and neck cancer.

T. Strom, T. Padhya, J. Russell, 2015, Oral oncology.

Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer

J. Jacobs, J. Ensley, J. Kish, 1987, Cancer.

A randomized trial of cisplatin (CACP) + 5‐fluorouracil (5‐FU) infusion and CACP + 5‐FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck

J. Jacobs, J. Ensley, J. Kish, 1985, Cancer.

The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer.

Christopher U. Jones, A. Garden, R. Weber, 2021, Journal of geriatric oncology.

Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high‐risk salivary gland carcinomas

T. Padhya, L. Harrison, J. Caudell, 2016, Head & neck.

The clinical syndrome of 5-fluorouracil cardiotoxicity

R. Kloner, J. Ensley, J. Wynne, 1989, Investigational New Drugs.

5‐Fluorouracil Cardiotoxicity: Left Ventricular Dysfunction and Effect of Coronary Vasodilators

R. Kloner, J. Ensley, J. Wynne, 1987, The American journal of the medical sciences.

A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis.

J. Hainsworth, J. Kish, P. Hesketh, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of fludarabine phosphate in malignant melanoma

K. Kopecky, F. Muggia, J. Kish, 1991, Investigational New Drugs.

A Phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149)

C. Rankin, K. Albain, H. Carraway, 2008, Journal of Neuro-Oncology.

The Incidence and significance of thromboembolic complications in patients with high‐grade gliomas

J. Ensley, J. Kish, M. al-Sarraf, 1991, Cancer.

Patterns of failure for resected advanced head & neck cancer treated by concurrent chemotherapy and radiation therapy: an analysis of RTOG 9501/intergroup phase III trial

J. Jacobs, T. Pajak, J. Cooper, 2002 .

Cisplatin and 5‐fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

J. Jacobs, J. Kish, M. al-Sarraf, 1984, Cancer.

Effect of prophylactic fluconazole on oral mucositis and candidiasis during radiation therapy for head-and-neck cancer.

R. Shridhar, M. Biagioli, J. Caudell, 2013, Practical radiation oncology.

Cis-platinum and 5-fluorouracil as induction therapy for advanced head and neck cancer.

J. Crissman, J. Kish, A. Weaver, 1982, American journal of surgery.

Increased acute mortality with chemoradiotherapy for locally advanced head and neck cancer in patients ≥70years.

T. Strom, L. Harrison, J. Russell, 2017, Journal of geriatric oncology.

Photo-chemotherapy in advanced head and neck cancer

J. Jacobs, J. Ensley, J. Crissman, 1987 .

The treatment challenge of hormone-refractory prostate cancer.

J. Kish, F. Palazzo, R. Bukkapatnam, 2001, Cancer control : journal of the Moffitt Cancer Center.

Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancer.

J. Jacobs, J. Ensley, J. Crissman, 1984, American journal of surgery.

The activity of a single‐agent 5‐fluorouracil infusion in advanced and recurrent head and neck cancer

J. Ensley, J. Kish, M. al-Sarraf, 1986, Cancer.

An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck cancer.

J. Jacobs, J. Ensley, J. Kish, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.

K. Ang, J. Jacobs, T. Pajak, 2012, International journal of radiation oncology, biology, physics.

Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck.

J. Jacobs, J. Kinzie, J. Kish, 1982, Cancer treatment reports.

A Multi-Center Retrospective Analysis Examining the Effect of Dipeptidyl Peptidase-4 Inhibitors on Progression-Free Survival in Patients With Prostate Cancer

N. Dang, L. Dang, J. Kish, 2021, Cureus.

Chemotherapy for paranasal sinus carcinoma. A 10‐year experience at Wayne state university

P. LoRusso, J. Ensley, J. Kish, 1988, Cancer.

Postoperative concurrent chemotherapy and radiotherapy for high‐risk cutaneous squamous cell carcinoma of the head and neck

T. Padhya, A. Trotti, J. Kish, 2015, Head & neck.

Combined modality therapy utilizing a cisplatin combination for effective chemotherapy in patients with previously untreated head and neck cancer.

J. Jacobs, J. Ensley, J. Crissman, 1986, American journal of surgery.

Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting.

J. Hainsworth, D. Gandara, J. Kish, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of low dose continuous infusion 5‐fluorouracil in patients with advanced and recurrent renal cell carcinoma. A Southwest Oncology Group study

R. Flanigan, J. Kish, J. Leimert, 1994, Cancer.

The role of infection in the morbidity and mortality of patients with head and neck cancer undergoing multimodality therapy

J. Ensley, M. Hussain, J. Kish, 1991, Cancer.

Intensity‐modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma

T. Padhya, J. Caudell, A. Trotti, 2013, Head & neck.

The Development of Maternal Confidence for Labor Among Nulliparous Pregnant Women

J. Kish, 2003 .

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.

L. Hutchins, J. Ensley, D. Schuller, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cellular DNA content parameters in untreated and recurrent squamous cell cancers of the head and neck.

J. Jacobs, J. Ensley, L. Heilbrun, 1989, Cytometry.

A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract Tumors

G. Bepler, M. Schell, S. Altiok, 2014, Clinical Cancer Research.

The correlation of specific variables of tumor differentiation with response rate and survival in patients with advanced head and neck cancer treated with induction chemotherapy

J. Jacobs, J. Ensley, J. Kish, 1989, Cancer.

Risk factors for percutaneous endoscopic gastrostomy tube placement during chemoradiotherapy for oropharyngeal cancer.

T. Strom, T. Padhya, Hui-Yi Lin, 2013, JAMA Otolaryngology - Head and Neck Surgery.

Correlation between response to cisplatinum‐combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck

J. Jacobs, J. Ensley, J. Crissman, 1984, Cancer.

Phase II evaluation of amonafide in renal cell carcinoma

P. Goodman, C. Higano, E. Crawford, 1991, Investigational New Drugs.

Ondansetron for nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

L. Cubeddu, J. Kish, P. Eisenberg, 1995, Clinical therapeutics.

Phase II multi-institutional clinical trial result of concurrent cetuximab and nivolumab in recurrent and/or metastatic head and neck squamous cell carcinoma.

Joaquim M Farinhas, P. Stephens, D. Shin, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Excellent Response to cis‐Platinum–Based Chemotherapy in Patients with Recurrent or Previously Untreated Advanced Nasopharyngeal Carcinoma

J. Ensley, J. Crissman, J. Kish, 1988, American journal of clinical oncology.

Evaluation of High‐Dose Cisplatin and 5‐FU Infusion as Initial Therapy in Advanced Head and Neck Cancer

J. Jacobs, J. Ensley, J. Kish, 1988, American journal of clinical oncology.

Continuous-infusion 5-fluorouracil and cisplatin for advanced/recurrent transitional cell cancer of the bladder: a Southwest Oncology Group trial.

P. Schellhammer, A. Einstein, E. Crawford, 1997, American journal of clinical oncology.

Fatal syncytial virus pneumonia in a laminar airflow room.

J. Kish, V. Ratanatharathorn, L. Crane, 1981, JAMA.

The Implementation of a Head and Neck Multidisciplinary Clinic and its Effects on Time to Treatment Initiation and Patient Satisfaction

L. Harrison, J. Caudell, A. Trotti, 2020 .

Neoadjuvant androgen ablation in localized carcinoma of the prostate.

J. Kish, 2001, Cancer control : journal of the Moffitt Cancer Center.

Proto-chemotherapy in advanced head and neck cancer.

J. Jacobs, J. Ensley, J. Crissman, 1987, Head & Neck Surgery.

Patient choice for high‐volume center radiation impacts head and neck cancer outcome

T. Strom, C. Chung, L. Harrison, 2018, Cancer medicine.

Using Big Data in oncology to prospectively impact clinical patient care: A proof of concept study.

Jongphil Kim, M. Extermann, L. Balducci, 2018, Journal of geriatric oncology.

Solid tumor preparation for clinical application of flow cytometry.

J. Jacobs, J. Ensley, Z. Maciorowski, 1987, Cytometry.

Patient‐reported outcomes in immunotherapy for head and neck cancer

H. Jim, B. Small, A. Hoogland, 2023, Head & neck.

A RANDOMIZED TRIAL OF CISPLATIN + 5-FU INFUSION AND CIS + 5-FU BOLUS FOR RECURRENT AND ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

J. Ensley, J. Kish, J. Jacob, 1985 .

Radiotherapy with Durvalumab vs. Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer and a Contraindication to Cisplatin: Phase II Results of NRG-HN004

S. Yom, A. Minn, L. Mell, 2022, International Journal of Radiation Oncology*Biology*Physics.

Safety of radiotherapy with concurrent and adjuvant MEDI4736 (durvalumab) in patients with locoregionally advanced head and neck cancer with a contraindication to cisplatin: NRG-HN004.

Steven S. Chang, Q. Le, A. Minn, 2019, Journal of Clinical Oncology.

Oncogeriatric Developments

M. Extermann, J. Kish, M. Al-Jumayli, 2023, Gerontology.

A multicenter retrospective analysis examining the effect of dipeptidyl protease 4 (DPP4) inhibitors on progression-free survival in patients with prostate cancer.

N. Dang, S. Patel, L. Dang, 2021 .

The effect of age on outcome in prospective, phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- chemotherapy in locally advanced (LA) head and neck cancer (HNC).

Christopher U. Jones, A. Garden, R. Weber, 2015 .